Measurable Residual IDH2 before Allogeneic Transplant for Acute Myeloid Leukemia

被引：1

作者：

Gui, Gege ^{[1
,2
]}

Dillon, Laura W. ^{[1
]}

Ravindra, Niveditha ^{[1
]}

Hegde, Pranay S. ^{[1
]}

Andrew, Georgia ^{[1
]}

Mukherjee, Devdeep ^{[1
]}

Wong, Zoe ^{[1
]}

Auletta, Jeffery J. ^{[3
,4
]}

El Chaer, Firas ^{[5
]}

Chen, Evan C. ^{[6
]}

Chen, Bin ^{[7
]}

Corner, Adam ^{[8
]}

Devine, Steven M. ^{[9
]}

Iyer, Sunil G. ^{[10
]}

Jimenez, Antonio M. Jimenez ^{[11
]}

De Lima, Marcos ^{[12
]}

Litzow, Mark R. ^{[13
]}

Kebriaei, Partow ^{[14
]}

Saber, Wael ^{[4
,15
]}

Spellman, Stephen R. ^{[4
,16
]}

Zeger, Scott L. ^{[2
]}

Page, Kristin M. ^{[4
,15
]}

Hourigan, Christopher S. ^{[17
]}

机构：

[1] Natl Heart Lung & Blood Inst, Hematol Branch, Lab Myeloid Malignancies, Bethesda, MD USA

[2] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD USA

[3] Nationwide Childrens Hosp, Hematol Oncol Bone Marrow Transplant & Infect Dis, Columbus, OH USA

[4] Ctr Int Blood & Marrow Transplant Res, Minneapolis, MN USA

[5] Univ Virginia, Div Hematol & Oncol, Dept Med, Comprehens Canc Ctr,Med Ctr, Charlottesville, VA USA

[6] Dana Farber Canc Inst, Boston, MA USA

[7] Massachusetts Gen Hosp, Boston, MA USA

[8] Biorad Labs, Pleasanton, CA USA

[9] Natl Marrow Donor Program Be Match, CIBMTR Ctr Int Blood & Marrow Transplant Res, Minneapolis, MN USA

[10] Columbia Univ, Div Hematol & Oncol, Herbert Irving Comprehens Canc Ctr, Irving Med Ctr, New York, NY USA

[11] Miller Sch Med, Sylvester Comprehens Canc Ctr, Miami, FL USA

[12] Ohio State Univ, Div Hematol, Wexner Med Ctr, Columbus, OH USA

[13] Mayo Clin, Div Hematol, Rochester, MN USA

[14] Univ Texas MD Anderson Canc Ctr, Dept Stem Cell Transplantat & Cellular Therapy, Houston, TX USA

[15] Med Coll Wisconsin, Milwaukee, WI USA

[16] Natl Marrow Donor Program, Minneapolis, MN USA

[17] NIH, Myeloid Malignancies Program, Bethesda, MD USA

来源：

BLOOD | 2023年 / 142卷

关键词：

D O I：

10.1182/blood-2023-186822

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：5

共 50 条

[1] Measurable residual mutated IDH2 before allogeneic transplant for acute myeloid leukemia
Gui, Gege
Ravindra, Niveditha
Hegde, Pranay S.
Andrew, Georgia
Mukherjee, Devdeep
Wong, Zoe
Auletta, Jeffery J.
El Chaer, Firas
Chen, Evan C.
Chen, Yi-Bin
Corner, Adam
Devine, Steven M.
Iyer, Sunil G.
Jimenez, Antonio Martin Jimenez
De Lima, Marcos J. G.
Litzow, Mark R.
Kebriaei, Partow
Saber, Wael
Spellman, Stephen R.
Zeger, Scott L.
Page, Kristin M.
Dillon, Laura W.
Hourigan, Christopher S.
BONE MARROW TRANSPLANTATION, 2025, 60 (02) : 144 - 153
[2] Measurable Residual IDH1 before Allogeneic Transplant for Acute Myeloid Leukemia
Gui, Gege
Dillon, Laura W.
Ravindra, Niveditha
Hegde, Pranay S.
Andrew, Georgia
Mukherjee, Devdeep
Wong, Zoe
Auletta, Jeffery J.
El Chaer, Firas
Chen, Evan C.
Chen, Yi-Bin
Corner, Adam
Devine, Steven M.
Iyer, Sunil G.
Jimenez, Antonio M. Jimenez
de Lima, Marcos
Litzow, Mark R.
Kebriaei, Partow
Saber, Wael
Spellman, Stephen R.
Zeger, Scott L.
Page, Kristin M.
Hourigan, Christopher S.
BLOOD, 2023, 142
[3] Measurable residual mutated IDH1 before allogeneic transplant for acute myeloid leukemia
Gui, Gege
Ravindra, Niveditha
Hegde, Pranay S.
Andrew, Georgia
Mukherjee, Devdeep
Wong, Zoe
Auletta, Jeffery J.
El Chaer, Firas
Chen, Evan C.
Chen, Yi-Bin
Corner, Adam
Devine, Steven M.
Iyer, Sunil G.
Jimenez Jimenez, Antonio Martin
De Lima, Marcos J. G.
Litzow, Mark R.
Kebriaei, Partow
Saber, Wael
Spellman, Stephen R.
Zeger, Scott L.
Page, Kristin M.
Dillon, Laura W.
Hourigan, Christopher S.
BONE MARROW TRANSPLANTATION, 2025, 60 (02) : 154 - 160
[4] Measurable Residual FLT3-ITD before Allogeneic Transplant for Acute Myeloid Leukemia
Dillon, Laura W.
Gui, Gege
Ravindra, Niveditha
Andrew, Georgia
Mukherjee, Devdeep
Wong, Zoe
Huang, Ying
Gerhold, Jason
Holman, Matthew
Miller, Jeffrey E.
Auletta, Jeffery J.
El Chaer, Firas
Devine, Steven M.
Jimenez, Antonio M. Jimenez
de Lima, Marcos
Litzow, Mark R.
Kebriaei, Partow
Saber, Wael
Spellman, Stephen R.
Page, Kristin M.
Hourigan, Christopher S.
BLOOD, 2023, 142
[5] Measurable residual disease in patients undergoing allogeneic transplant for acute myeloid leukemia
Wong, Zoe C.
Dillon, Laura W.
Hourigan, Christopher S.
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2023, 36 (02)
[6] IDH2 mutations in acute myeloid leukemia
Babakhanlou, Rodrick
DiNardo, Courtney
Borthakur, Gautam
LEUKEMIA & LYMPHOMA, 2023, 64 (11) : 1733 - 1741
[7] Measurable Residual FLT3 Internal Tandem Duplication Before Allogeneic Transplant for Acute Myeloid Leukemia
Dillon, Laura W.
Gui, Gege
Ravindra, Niveditha
Andrew, Georgia
Mukherjee, Devdeep
Wong, Zoe C.
Huang, Ying
Gerhold, Jason
Holman, Matt
D'Angelo, Julian
Miller, Jeffrey
Higgins, Jake
Salk, Jesse J.
Auletta, Jeffery J.
El Chaer, Firas
Devine, Steven M.
Jimenez-Jimenez, Antonio Martin
De Lima, Marcos J. G.
Litzow, Mark R.
Kebriaei, Partow
Saber, Wael
Spellman, Stephen R.
Zeger, Scott L.
Page, Kristin M.
Hourigan, Christopher S.
JAMA ONCOLOGY, 2024, 10 (08) : 1104 - 1110
[8] Measurable residual FLT3 tyrosine kinase domain mutations before allogeneic transplant for acute myeloid leukemia
Hegde, Pranay S.
Andrew, Georgia
Gui, Gege
Ravindra, Niveditha
Mukherjee, Devdeep
Wong, Zoe C.
Auletta, Jeffery J.
El Chaer, Firas
Corner, Adam
Devine, Steven M.
Jimenez Jimenez, Antonio Martin
De Lima, Marcos J. G.
Litzow, Mark R.
Kebriaei, Partow
Saber, Wael
Spellman, Stephen R.
Zeger, Scott L.
Page, Kristin M.
Dillon, Laura W.
Hourigan, Christopher S.
BONE MARROW TRANSPLANTATION, 2025, 60 (02) : 175 - 177
[9] Targeting the IDH2 Pathway in Acute Myeloid Leukemia
Amaya, Maria L.
Pollyea, Daniel A.
CLINICAL CANCER RESEARCH, 2018, 24 (20) : 4931 - 4936
[10] IDH1/IDH2 Inhibition in Acute Myeloid Leukemia
Cerchione, Claudio
Romano, Alessandra
Daver, Naval
DiNardo, Courtney
Jabbour, Elias Joseph
Konopleva, Marina
Ravandi-Kashani, Farhad
Kadia, Tapan
Martelli, Maria Paola
Isidori, Alessandro
Martinelli, Giovanni
Kantarjian, Hagop
FRONTIERS IN ONCOLOGY, 2021, 11

← 1 2 3 4 5 →